Atrasentan [atrasentan]
topical
6
- Terms
-
Xinlay
-
(11C)ABT-627
2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid
A 127722
A 147627
A-127722
A-127722.5
A-147627
ABT 627
ABT-627
Atrasentan Hydrochloride
Xinlay
Persistent link
https://www.medvik.cz/link/D000077868
Definition
A pyrrolidine and benzodioxole derivative that acts a RECEPTOR, ENDOTHELIN A antagonist. It has therapeutic potential as an antineoplastic agent and for the treatment of DIABETIC NEPHROPATHIES.
- DUI
- D000077868 MeSH Browser
- CUI
- M0393223
- CAS
- 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-
- History note
- 2019 (1996)
- Public note
- 2019; ATRASENTAN was indexed under PYRROLIDINES 1996-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 1
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.773.170
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
1
D03.383.773.371
Imino Furanoses
D03.383.773.589
Nafoxidine
D03.383.773.610
Nitromifene
D03.383.773.630
N-Nitrosopyrrolidine